AU2002364456A8 - Use of compounds of the benzamide family as immunosuppressant - Google Patents

Use of compounds of the benzamide family as immunosuppressant

Info

Publication number
AU2002364456A8
AU2002364456A8 AU2002364456A AU2002364456A AU2002364456A8 AU 2002364456 A8 AU2002364456 A8 AU 2002364456A8 AU 2002364456 A AU2002364456 A AU 2002364456A AU 2002364456 A AU2002364456 A AU 2002364456A AU 2002364456 A8 AU2002364456 A8 AU 2002364456A8
Authority
AU
Australia
Prior art keywords
immunosuppressant
compounds
benzamide
family
benzamide family
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2002364456A
Other versions
AU2002364456A1 (en
Inventor
Jean-Michel Robert
Francois Lang
Jean-Yves Petit
Delphine Carbonnelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Nantes
Original Assignee
Universite de Nantes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Nantes filed Critical Universite de Nantes
Publication of AU2002364456A8 publication Critical patent/AU2002364456A8/en
Publication of AU2002364456A1 publication Critical patent/AU2002364456A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
AU2002364456A 2001-12-19 2002-12-18 Use of compounds of the benzamide family as immunosuppressant Abandoned AU2002364456A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0116443A FR2833494B1 (en) 2001-12-19 2001-12-19 USE OF BENZAMIDE FAMILY COMPOUNDS AS IMMUNOSUPPRESSANT AGENT
FR01/16443 2001-12-19
PCT/FR2002/004415 WO2003051365A2 (en) 2001-12-19 2002-12-18 Use of compounds of the benzamide family as immunosuppressant

Publications (2)

Publication Number Publication Date
AU2002364456A8 true AU2002364456A8 (en) 2003-06-30
AU2002364456A1 AU2002364456A1 (en) 2003-06-30

Family

ID=8870680

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002364456A Abandoned AU2002364456A1 (en) 2001-12-19 2002-12-18 Use of compounds of the benzamide family as immunosuppressant

Country Status (3)

Country Link
AU (1) AU2002364456A1 (en)
FR (1) FR2833494B1 (en)
WO (1) WO2003051365A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0784462B2 (en) * 1986-07-25 1995-09-13 日清製粉株式会社 Benzimidazole derivative
FR2707085B1 (en) * 1993-06-30 1995-08-18 Adir New alpha amino acid derivatives, process for their preparation and pharmaceutical compositions containing them.
FR2720396B1 (en) * 1994-05-27 1996-06-28 Adir New N-pyridyl carboxamides and derivatives, their preparation process and the pharmaceutical compositions containing them.

Also Published As

Publication number Publication date
FR2833494B1 (en) 2006-12-15
FR2833494A1 (en) 2003-06-20
WO2003051365A2 (en) 2003-06-26
WO2003051365A9 (en) 2004-05-06
AU2002364456A1 (en) 2003-06-30
WO2003051365A3 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
ZA200305691B (en) The use of substituted azetidione compounds for the treatment of sitosterolemia
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
PL359064A1 (en) Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
IL157426A0 (en) Peg-conjugates of hgf-nk4
EP1461030A4 (en) Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
PL369028A1 (en) Fungicidal mixture
PL366437A1 (en) Use of substituted imidazo 1,2-a]-pyridine-3-yl-amide and imidazo 1,2-a]-pyridine-3-yl-amine compounds as medicaments
EP1434593A4 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
AU2002364456A8 (en) Use of compounds of the benzamide family as immunosuppressant
TW493722U (en) Improved structure of lampwick
IL157243A0 (en) Preparation of n-methylparoxetine and related intermediate compounds
TW573751U (en) Structure capable of preventing jaming
HU0104370D0 (en) Honeyed schnaps of oerseg
GB0124732D0 (en) Use of organic compounds
GB0104840D0 (en) Use of organic compounds
TW512752U (en) Purifier of organic compounds
TW512701U (en) Structure of assembled bed
TW533809U (en) Structure of mattress set
GB0109520D0 (en) Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as njk-inhibitors
CA92259S (en) Set of furniture
CA91421S (en) Set of furniture
GB0112544D0 (en) Novel use and compounds
GB0218043D0 (en) New use of diaza-anthracene compounds
GB0217750D0 (en) New use of diaza-anthracene compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase